• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抑郁动物模型中海马胰岛素和胰高血糖素样肽-1水平及其对下丘脑细胞系促肾上腺皮质激素释放激素启动子基因活性的影响。

Hypothalamic insulin and glucagon-like peptide-1 levels in an animal model of depression and their effect on corticotropin-releasing hormone promoter gene activity in a hypothalamic cell line.

机构信息

Department of Experimental Neuroendocrinology, Institute of Pharmacology, Polish Academy of Sciences, Kraków, Poland.

Department of Experimental Neuroendocrinology, Institute of Pharmacology, Polish Academy of Sciences, Kraków, Poland.

出版信息

Pharmacol Rep. 2019 Apr;71(2):338-346. doi: 10.1016/j.pharep.2018.11.001. Epub 2018 Nov 27.

DOI:10.1016/j.pharep.2018.11.001
PMID:30831439
Abstract

BACKGROUND

In depression, excessive glucocorticoid action may cause maladaptive brain changes, including in the pathways controlling energy metabolism. Insulin and glucagon-like peptide-1 (GLP-1), besides regulation of glucose homeostasis, also possess neurotrophic properties. Current study was aimed at investigating the influence of prenatal stress (PS) on insulin, GLP-1 and their receptor (IR and GLP-1R) levels in the hypothalamus. GLP-1 and GLP-1R were assayed also in the hippocampus and frontal cortex - brain regions mainly affected in depression. The second objective was to determine the influence of exendin-4 and insulin on CRH promoter gene activity in in vitro conditions.

METHODS

Adult male PS rats were subjected to acute stress and/or received orally glucose. Levels of hormones and their receptors were assayed with ELISA method. In vitro studies were performed on mHypoA-2/12 hypothalamic cell line, stably transfected with CRH promoter coupled with luciferase.

RESULTS

PS has reduced GLP-1 and GLP-1R levels, attenuated glucose-induced increase in insulin concentration and increased the amount of phosphorylated IR in the hypothalamus of animals subjected to additional stress stimuli, and also decreased the GLP-1R level in the hippocampus. In vitro studies demonstrated that insulin is capable of increasing CRH promoter activity in the condition of stimulation of the cAMP/PKA pathway in the applied cellular model.

CONCLUSION

Prenatal stress may act as a preconditioning factor, affecting the concentrations of hormones such as insulin and GLP-1 in the hypothalamus in response to adverse stimuli. The decreased GLP-1R level in the hippocampus could be linked with the disturbances in neuronal plasticity.

摘要

背景

在抑郁症中,过量的糖皮质激素作用可能导致适应性脑改变,包括控制能量代谢的途径。胰岛素和胰高血糖素样肽-1(GLP-1)除了调节葡萄糖稳态外,还具有神经营养特性。本研究旨在研究产前应激(PS)对下丘脑胰岛素、GLP-1及其受体(IR 和 GLP-1R)水平的影响。还在海马体和前额皮质中测定了 GLP-1 和 GLP-1R - 抑郁症主要影响的脑区。第二个目的是确定外泌素-4 和胰岛素对体外条件下 CRH 启动子基因活性的影响。

方法

成年雄性 PS 大鼠接受急性应激和/或口服葡萄糖。用 ELISA 法测定激素及其受体的水平。体外研究在 mHypoA-2/12 下丘脑细胞系上进行,该细胞系稳定转染与荧光素酶偶联的 CRH 启动子。

结果

PS 降低了 GLP-1 和 GLP-1R 水平,减弱了葡萄糖诱导的胰岛素浓度增加,并增加了接受额外应激刺激的动物下丘脑的磷酸化 IR 量,同时降低了海马体中的 GLP-1R 水平。体外研究表明,胰岛素能够在应用细胞模型中 cAMP/PKA 途径刺激的条件下增加 CRH 启动子活性。

结论

产前应激可能作为一种预处理因素,影响下丘脑激素如胰岛素和 GLP-1 的浓度,以应对不良刺激。海马体中 GLP-1R 水平的降低可能与神经元可塑性的紊乱有关。

相似文献

1
Hypothalamic insulin and glucagon-like peptide-1 levels in an animal model of depression and their effect on corticotropin-releasing hormone promoter gene activity in a hypothalamic cell line.抑郁动物模型中海马胰岛素和胰高血糖素样肽-1水平及其对下丘脑细胞系促肾上腺皮质激素释放激素启动子基因活性的影响。
Pharmacol Rep. 2019 Apr;71(2):338-346. doi: 10.1016/j.pharep.2018.11.001. Epub 2018 Nov 27.
2
Action of glucagon-like peptide 1 and glucose levels on corticotropin-releasing factor and vasopressin gene expression in rat hypothalamic 4B cells.胰高血糖素样肽 1 和血糖水平对大鼠下丘脑 4B 细胞中促肾上腺皮质激素释放因子和血管加压素基因表达的作用。
Mol Cell Endocrinol. 2012 Oct 15;362(1-2):221-6. doi: 10.1016/j.mce.2012.06.023. Epub 2012 Jul 16.
3
Glucagon-like peptide-1, corticotropin-releasing hormone, and hypothalamic neuronal histamine interact in the leptin-signaling pathway to regulate feeding behavior.胰高血糖素样肽-1、促肾上腺皮质激素释放激素和下丘脑神经元组胺在瘦素信号通路中相互作用,以调节摄食行为。
FASEB J. 2005 Jul;19(9):1131-3. doi: 10.1096/fj.04-2384fje. Epub 2005 May 13.
4
Acute activation of central GLP-1 receptors enhances hepatic insulin action and insulin secretion in high-fat-fed, insulin resistant mice.高脂喂养、胰岛素抵抗的小鼠中,中枢 GLP-1 受体的急性激活增强了肝脏的胰岛素作用和胰岛素分泌。
Am J Physiol Endocrinol Metab. 2012 Feb 1;302(3):E334-43. doi: 10.1152/ajpendo.00409.2011. Epub 2011 Nov 15.
5
Glucagon like peptide-1 (7-36) amide (GLP-1) nerve terminals densely innervate corticotropin-releasing hormone neurons in the hypothalamic paraventricular nucleus.胰高血糖素样肽-1(7-36)酰胺(GLP-1)神经末梢密集支配下丘脑室旁核中的促肾上腺皮质激素释放激素神经元。
Brain Res. 2003 Sep 26;985(2):163-8. doi: 10.1016/s0006-8993(03)03117-2.
6
Brain glucagon-like peptide-1 regulates arterial blood flow, heart rate, and insulin sensitivity.大脑胰高血糖素样肽-1调节动脉血流量、心率和胰岛素敏感性。
Diabetes. 2008 Oct;57(10):2577-87. doi: 10.2337/db08-0121. Epub 2008 Jul 15.
7
Regulation of brain insulin mRNA by glucose and glucagon-like peptide 1.葡萄糖和胰高血糖素样肽1对脑胰岛素mRNA的调节
Biochem Biophys Res Commun. 2008 Nov 28;376(4):694-9. doi: 10.1016/j.bbrc.2008.09.054. Epub 2008 Sep 20.
8
Brain GLP-1 signaling regulates femoral artery blood flow and insulin sensitivity through hypothalamic PKC-δ.脑 GLP-1 信号通过下丘脑 PKC-δ 调节股动脉血流和胰岛素敏感性。
Diabetes. 2011 Sep;60(9):2245-56. doi: 10.2337/db11-0464. Epub 2011 Aug 1.
9
Loss of dorsomedial hypothalamic GLP-1 signaling reduces BAT thermogenesis and increases adiposity.背内侧下丘脑 GLP-1 信号的丧失会减少 BAT 产热并增加肥胖。
Mol Metab. 2018 May;11:33-46. doi: 10.1016/j.molmet.2018.03.008. Epub 2018 Mar 21.
10
Central administration of glucagon-like peptide-1 activates hypothalamic neuroendocrine neurons in the rat.胰高血糖素样肽-1的中枢给药激活大鼠下丘脑神经内分泌神经元。
Endocrinology. 1997 Oct;138(10):4445-55. doi: 10.1210/endo.138.10.5270.

引用本文的文献

1
Psychiatric adverse events associated with GLP-1 receptor agonists: a real-world pharmacovigilance study based on the FDA Adverse Event Reporting System database.GLP-1 受体激动剂相关的精神不良事件:基于 FDA 不良事件报告系统数据库的真实世界药物警戒研究。
Front Endocrinol (Lausanne). 2024 Feb 6;15:1330936. doi: 10.3389/fendo.2024.1330936. eCollection 2024.
2
Natural products for the treatment of depression: Insights into signal pathways influencing the hypothalamic-pituitary-adrenal axis.天然产物治疗抑郁症:影响下丘脑-垂体-肾上腺轴的信号通路的见解。
Medicine (Baltimore). 2023 Nov 3;102(44):e35862. doi: 10.1097/MD.0000000000035862.
3
Changes in regulators of lipid metabolism in the brain: a study of animal models of depression and hypothyroidism.
大脑脂质代谢调节因子的变化:抑郁症和甲状腺功能减退症动物模型的研究。
Pharmacol Rep. 2022 Oct;74(5):859-870. doi: 10.1007/s43440-022-00395-8. Epub 2022 Aug 11.
4
The effects of exercise and diet on mental status, insulin signaling pathway, and microbiome in obese mice.运动和饮食对肥胖小鼠精神状态、胰岛素信号通路及微生物群的影响。
J Exerc Rehabil. 2022 Jun 27;18(3):171-178. doi: 10.12965/jer.2244278.139. eCollection 2022 Jun.
5
Insights into a possible role of glucagon-like peptide-1 receptor agonists in the treatment of depression.探讨胰高血糖素样肽-1 受体激动剂在治疗抑郁症中的可能作用。
Pharmacol Rep. 2021 Aug;73(4):1020-1032. doi: 10.1007/s43440-021-00274-8. Epub 2021 May 18.
6
Analysis of Chronic Mild Stress-Induced Hypothalamic Proteome: Identification of Protein Dysregulations Associated With Vulnerability and Resiliency to Depression or Anxiety.慢性轻度应激诱导的下丘脑蛋白质组分析:与抑郁症或焦虑症易感性和恢复力相关的蛋白质失调鉴定
Front Mol Neurosci. 2021 Mar 2;14:633398. doi: 10.3389/fnmol.2021.633398. eCollection 2021.
7
Potential role of insulin on the pathogenesis of depression.胰岛素在抑郁症发病机制中的潜在作用。
Cell Prolif. 2020 May;53(5):e12806. doi: 10.1111/cpr.12806. Epub 2020 Apr 13.
8
Association between GLP-1 receptor gene polymorphisms with reward learning, anhedonia and depression diagnosis.GLP-1 受体基因多态性与奖赏学习、快感缺失和抑郁诊断的关系。
Acta Neuropsychiatr. 2020 Aug;32(4):218-225. doi: 10.1017/neu.2020.14. Epub 2020 Mar 26.
9
The Potential Role of Dysfunctions in Neuron-Microglia Communication in the Pathogenesis of Brain Disorders.神经元-小胶质细胞通讯功能障碍在脑疾病发病机制中的潜在作用。
Curr Neuropharmacol. 2020;18(5):408-430. doi: 10.2174/1570159X17666191113101629.